Last reviewed · How we verify

NCT03667352

Efficacy Of Scalp Block And Ultrasound Guided TAP Block With Clonidine As Adjuvant To Ropivacaine Versus Intravenous Fentanyl On Intraoperative Hemodynamics And Perioperative Analgesia In Abdominal Bone Flap Cranioplasties

Completed Phase 4 Last updated 14 September 2018
What this trial tests

Phase 4 trial testing Unilateral Scalp Block in Condition: Abdominal Bone Flap Cranioplasty; Focus of Study: Perioperative Analgesia in 60 participants. Completed in 15 May 2018.

Timeline
15 July 2017
Primary endpoint
15 May 2018
15 May 2018

Quick facts

Lead sponsorDhritiman Chakrabarti
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date15 July 2017
Primary completion15 May 2018
Estimated completion15 May 2018
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Dhritiman Chakrabarti

Who can join

Adults 18 to 65, any sex, with Condition: Abdominal Bone Flap Cranioplasty; Focus of Study: Perioperative Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses efficacy of scalp block and Ultrasound guided transverse abdominis plane (TAP) block with 1µg/kg clonidine as adjuvant to 0.2% ropivacaine versus intravenous fentanyl (0.1µg/kg/hr) on intraoperative hemodynamics and perioperative analgesia in abdominal bone flap cranioplasties (ABFC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dhritiman Chakrabarti trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03667352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing